English
Arabic
Chinese (Simplified)
Dutch
French
German
Hebrew
Italian
Japanese
Portuguese
Russian
Spanish
DOI:10.25259/SNI_494_2021_ER
Copyright: © 2021 Surgical Neurology International This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.How to cite this article: . Erratum: Prospective comparative study of intraoperative balloon electronic brachytherapy versus resection with multidisciplinary adjuvant therapy for recurrent glioblastoma. 10-Dec-2021;12:607
How to cite this URL: . Erratum: Prospective comparative study of intraoperative balloon electronic brachytherapy versus resection with multidisciplinary adjuvant therapy for recurrent glioblastoma. 10-Dec-2021;12:607. Available from: https://surgicalneurologyint.com/surgicalint-articles/11283/
Date of Submission
Date of Acceptance
Date of Web Publication
10-Dec-2021
In the article entitled “Prospective comparative study of intraoperative balloon electronic brachytherapy versus resection with multidisciplinary adjuvant therapy for recurrent glioblastoma” published in Surgical Neurology International[ Figure 3 legend is incorrectly written as Kaplan-Meier curves for overall survival in the intraoperative balloon electronic brachytherapy group stratified according to postoperative residual contrast-enhanced volume (PCEV): the subgroup of subjects with PCEV >2.5 cm3 marked in red, the subgroup of subjects with PCEV ≤2.5 cm3 marked in green; log rank χ2 = 8.03, P = 0.005, P < 0.05 instead of Kaplan-Meier curves for overall survival in the intraoperative balloon electronic brachytherapy group stratified according to postoperative residual contrast-enhanced volume (PCEV): the subgroup of subjects with PCEV >2.5 cm3 marked in green, the subgroup of subjects with PCEV ≤2.5 cm3 marked in red; log rank c2 = 8.03, P = 0.005, P < 0.05. Figure 4 legend is incorrectly written as Kaplan-Meier curves for overall survival: The intraoperative balloon electronic brachytherapy group marked in green, the control group marked in red; Log Rank c2 = 4.23, P = 0.04, P < 0.05 instead of Kaplan-Meier curves for overall survival: The intraoperative balloon electronic brachytherapy group marked in red, the control group marked in green; Log Rank c2 = 4.23, P = 0.04, P < 0.05. Figure 5 legend is incorrectly written as Kaplan-Meier curves for local progression-free survival: the intraoperative balloon electronic brachytherapy group marked in green, the control group marked in red, Log Rank c2 = 4.93, P = 0.026, P < 0.05 instead of Kaplan-Meier curves for local progression-free survival: the intraoperative balloon electronic brachytherapy group marked in red, the control group marked in green, Log Rank c2 = 4.93, P = 0.026, P < 0.05. Figure 6 legend is incorrectly written as Kaplan-Meier curves for overall survival in the subgroups of subjects with postoperative residual contrast-enhanced volume ≤2.5 cm3: the intraoperative balloon electronic brachytherapy group marked in green, the control group marked in red; Log Rank c2 = 4.13, P = 0.042, P < 0.05 instead of Kaplan-Meier curves for overall survival in the subgroups of subjects with postoperative residual contrast-enhanced volume ≤2.5 cm3: the intraoperative balloon electronic brachytherapy group marked in red, the control group marked in green; Log Rank c2 = 4.13, P = 0.042, P < 0.05. Figure 7 legend is incorrectly written as Kaplan-Meier curves for local progression-free survival in the subgroups of subjects with postoperative residual contrast-enhanced volume ≤2.5 cm3: the intraoperative balloon electronic brachytherapy group marked in green, the control group marked in red; Log Rank c2 = 7.24, P = 0.007, P < 0.05 instead of Kaplan-Meier curves for local progression-free survival in the subgroups of subjects with postoperative residual contrast-enhanced volume ≤2.5 cm3: the intraoperative balloon electronic brachytherapy group marked in red, the control group marked in green; Log Rank c2 = 7.24, P = 0.007, P < 0.05. In Tables 3 and 5 Current status is incorrectly written as October 2020 instead of March 2021.
References
1. Krivoshapkin A, Gaytan A, Abdullaev O, Salim N, Sergeev G, Marmazeev I. Prospective comparative study of intraoperative balloon electronic brachytherapy versus resection with multidisciplinary adjuvant therapy for recurrent glioblastoma. Surg Neurol Int. 2021. 12: 517
